Analyst picks & changes

By BC Staff | May 3, 2004 | 7:00 AM GMT

(DNA), South San Francisco, Calif.

OSI Pharmaceuticals Inc.

(OSIP), Melville, N.Y.

Business: Cancer

Lazard analyst Joel Sendek increased

Read the full 202 word article

How to gain access

Continue reading with a
two-week free trial.